Cryo-EM structure of Alzheimer's disease tau filaments with PET ligand MK-6240.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 39353896.
- Also identified by DOI 10.1038/s41467-024-52265-x and PMC identifier 11445244.
- Licence recorded as CC BY-NC-ND.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Positron Emission Tomography (PET) ligands have advanced Alzheimer's disease (AD) diagnosis and treatment. Using autoradiography and cryo-EM, we identify AD brain tissue with elevated tau burden, purify filaments, and determine the structure of second-generation high avidity PET ligand MK-6240 at 2.31 Å resolution, which bound at a 1:1 ratio within the cleft of tau paired-helical filament (PHF), engaging with glutamine 351, lysine 353, and isoleucine 360. This information elucidates the basis of MK-6240 PET in quantifying PHF deposits in AD and may facilitate the structure-based design of superior ligands against tau amyloids.
Medical subject headings
- Alzheimer Disease
- tau Proteins
- Positron-Emission Tomography
- Cryoelectron Microscopy